Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon
<p>Polycythemia vera (PV) is a clonal disorder arising from the acquired somatic mutations of the <em>JAK2</em> gene, including <em>JAK2</em><sup>V617F</sup> or several others in exon 12. A 38-year-old female had a stroke...
Auteurs principaux: | Song, J, Lanikova, L, Kim, SJ, Papadopoulos, N, Meznarich, J, Constantinescu, SN, Parsegov, B, Prchal, JF, Prchal, JT |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Wiley
2024
|
Documents similaires
-
Germline counterparts of oncogenic mutations: who gives a JAK?.
par: Mead, A, et autres
Publié: (2013) -
Germline activating JAK2-mutation in a family with hereditary thrombocytosis
par: Mead, A, et autres
Publié: (2012) -
Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
par: Mead, A, et autres
Publié: (2013) -
Germline JAK2 mutation in a family with hereditary thrombocytosis.
par: Mead, A, et autres
Publié: (2012) -
Degrading JAK2 in ALL by ruxolitinib-based PROTACs
par: Constantinescu, SN, et autres
Publié: (2021)